반응식
C[C:2]([C:5]1[CH:6]=[C:7]([CH2:16][N:17]2[CH2:22][CH2:21][NH:20][CH2:19][CH2:18]2)[CH:8]=[C:9]([C:12]([CH3:15])([CH3:14])[CH3:13])[C:10]=1[OH:11])(C)C.CC(C1C=C(C=C(C)C=1O)C=O)(C)C.CC(C1C=C(C=C(C(C)(C)C)C=1O)C=O)(C)C>>[CH3:15][C:12]([C:9]1[CH:8]=[C:7]([CH2:16][N:17]2[CH2:18][CH2:19][NH:20][CH2:21][CH2:22]2)[CH:6]=[C:5]([CH3:2])[C:10]=1[OH:11])([CH3:13])[CH3:14]참가 물질
4
실험 절차
This was prepared using the general methodology described for the preparation of 1-(3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)methylpiperazine except that 3-(1,1-dimethylethyl)-4-hydroxy-5-methylbenzaldehyde replaced the 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzaldehyde.
후처리
- customThis was prepared
출처 및 근거
- ORD 기록
- ord-3a6afa8eaeee4e318d2d422f9f6420e1
- 출처 데이터셋
- uspto-grants-2001_05
- 특허 번호
- US06232314B1
연결된 노트
불러오는 중…